Search results for: CANCER

• INTERNATIONAL JOURNAL OF CANCER

  Journals

  ISSN: 0020-7136 , eISSN: 1097-0215

• EUROPEAN JOURNAL OF CANCER

  Journals

  ISSN: 0959-8049 , eISSN: 1879-0852

• CANCER-AM CANCER SOC

  Journals

  ISSN: 0008-543X , eISSN: 1097-0142

• BMC CANCER

  Journals

  ISSN: 1471-2407

• BRITISH JOURNAL OF CANCER

  Journals

  ISSN: 0007-0920 , eISSN: 1532-1827

• Metabolomics in urogenital cancer

  Publication

  • R. Bujak
  • E. Daghir
  • J. Rybka
  • P. Koslinski
  • M. Markuszewski

  - BIOANALYSIS - Year 2011

  Full text to download in external service

• Effect Of Resveratrol And Quercetin On Telomerase Regulation In Cancer Cells And Their Anti-Cancer Potential

  Publication

  • W. Brankiewicz

  - Year 2019

  Telomeres and telomerase are nowadays one on targets for anticancer therapy. Telomerase is expressed in ~90% of human cancer cell lines and tumor specimens, whereas its enzymatic activity is not detectable in most human somatic cells. Was found that some dietary compounds can modulate telomerase activity in cancer cells. This review summarizes the current knowledge about the effects of resveratrol and quercetin on telomerase regulation...

• Lung cancer survival and comorbidities in lung cancer screening participants of the Gdańsk screening cohort

  Publication

  • M. Ostrowski
  • M. Marczyk
  • R. Dziedzic
  • M. Jelitto-Górska
  • T. Marjański
  • S. Pisiak
  • T. Jędrzejczyk
  • J. Polańska
  • T. Zdrojewski
  • B. Wojtyniak... and 2 others

  - EUROPEAN JOURNAL OF PUBLIC HEALTH - Year 2019

  Full text to download in external service

• The Assessment of Cancer-Related Fatigue Syndrome in Patients with Lung Cancer during Palliative Chemotherapy

  Publication

  • A. Nowicki
  • J. Piekarska
  • P. Farbicka

  - Advances in Respiratory Medicine - Year 2017

  Full text to download in external service

• CANCER NURSING

  Journals

  ISSN: 0162-220X , eISSN: 1538-9804

• CANCER RESEARCH

  Journals

  ISSN: 0008-5472 , eISSN: 1538-7445

• CANCER IMAGING

  Journals

  ISSN: 1470-7330 , eISSN: 1740-5025

• CANCER CYTOPATHOLOGY

  Journals

  ISSN: 1934-662X , eISSN: 1934-6638

• Cancer Biomarkers

  Journals

  ISSN: 1574-0153 , eISSN: 1875-8592

• CANCER JOURNAL

  Journals

  ISSN: 1528-9117 , eISSN: 1540-336X

• CANCER CELL

  Journals

  ISSN: 1535-6108 , eISSN: 1878-3686

• Cancer Radiotherapie

  Journals

  ISSN: 1278-3218 , eISSN: 1769-6658

• CANCER INVESTIGATION

  Journals

  ISSN: 0735-7907 , eISSN: 1532-4192

• Cancer Microenvironment

  Journals

  ISSN: 1875-2292 , eISSN: 1875-2284

• Hormones & Cancer

  Journals

  ISSN: 1868-8497 , eISSN: 1868-8500

• Colorectal Cancer

  Journals

  ISSN: 1758-194X , eISSN: 1758-1958

• Thoracic Cancer

  Journals

  ISSN: 1759-7706 , eISSN: 1759-7714

• Cancer Control

  Journals

  ISSN: 1073-2748

• Cancer Informatics

  Journals

  ISSN: 1176-9351

• Familial Cancer

  Journals

  ISSN: 1389-9600 , eISSN: 1573-7292

• Cancer Genetics

  Journals

  ISSN: 2210-7762 , eISSN: 2210-7770

• Cancer Communications

  Journals

  ISSN: 2523-3548

• CANCER SCIENCE

  Journals

  ISSN: 1349-7006 , eISSN: 1347-9032

• Cancer Forum

  Journals

  ISSN: 0311-306X

• Cancer Discovery

  Journals

  ISSN: 2159-8274 , eISSN: 2159-8290

• Cancer & Metabolism

  Journals

  ISSN: 2049-3002

• Bladder Cancer

  Journals

  ISSN: 2352-3727 , eISSN: 2352-3735

• Prostate Cancer

  Journals

  ISSN: 2090-3111 , eISSN: 2090-312X

• Genes and Cancer

  Journals

  ISSN: 1947-6019

• Liver Cancer

  Journals

  ISSN: 2235-1795 , eISSN: 1664-5553

• Trends in Cancer

  Journals

  ISSN: 2405-8025 , eISSN: 2405-8033

• Cancer Journal

  Journals

  ISSN: 0765-7846

• JMIR Cancer

  Journals

  ISSN: 2369-1999

• Kidney Cancer

  Journals

  ISSN: 2468-4562 , eISSN: 2468-4570

• NAR Cancer

  Journals

  ISSN: 2632-8674

• Nature Cancer

  Journals

  eISSN: 2662-1347

• Cancer Reports

  Journals

  eISSN: 2573-8348

• Antihypertensive therapy and cancer risks?

  Publication

  • T. Hedner
  • K. Narkiewicz
  • S. Kjeldsen
  • S. Oparil

  - BLOOD PRESSURE - Year 2011

  Full text to download in external service

• Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - a pilot study

  Publication

  • M. Roś-Mazurczyk
  • A. Wojakowska
  • Ł. Marczak
  • K. Polański
  • M. Pietrowska
  • J. Polanska
  • R. Dziadziuszko
  • J. Jassem
  • W. Rzyman
  • P. Widlak

  - Acta Biochimica Polonica - Year 2017

  Full text to download in external service

• Tiliroside Combined with Anti-MUC1 Monoclonal Antibody as Promising Anti-Cancer Strategy in AGS Cancer Cells

  Publication

  • I. Radziejewska
  • K. Supruniuk
  • K. Jakimiuk
  • M. Tomczyk
  • A. Bielawska
  • A. Galicka

  - International Journal of Molecular Sciences - Year 2023

  Full text to download in external service

• Assessment of Pain Management, Acceptance of Illness, and Adjustment to Life with Cancer in Patients with Nonmuscle Invasive Bladder Cancer

  Publication

  • W. Krajewski
  • M. Mazur
  • A. Poterek
  • A. Pastuszak
  • U. Halska
  • A. Tukiendorf
  • J. Rymaszewska
  • R. Zdrojowy

  - Biomed Research International - Year 2018

  Full text to download in external service

• Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?

  Publication

  • K. Kaźmierczak-Siedlecka
  • N. Bulman
  • P. Ulasiński
  • B. K. Sobocki
  • K. Polom
  • L. Marano
  • L. Kalinowski
  • K. Skonieczna-Żydecka

  - Gut Microbes - Year 2023

  Intestinal bacteria are equipped with an enzyme apparatus that is involved in the active biotrans-formation of xenobiotics, including drugs. Pharmacomicrobiomics, a new area of pharmacology, analyses interactions between bacteria and xenobiotics. However, there is another side to the coin. Pharmacotherapeutic agents can significantly modify the microbiota, which consequently affects their efficacy. In this review, we comprehensively...

  Full text available to download

• Initial assessment of suitability of MCF-7 and HepG2 cancer cell lines for AQP3 research in cancer biology

  Publication

  • P. Oberska
  • M. Jedrzejczak-Silicka
  • K. M. Michałek
  • M. Grabowska

  - ACTA HISTOCHEMICA - Year 2021

  Full text to download in external service

• Gold nanoparticles for cancer radiotherapy: a review

  Publication

  • K. Haume
  • S. Rosa
  • S. Grellet
  • M. Śmiałek-Telega
  • K. Butterworth
  • A. V. Solov’yov
  • K. Prise
  • J. Golding
  • N. J. Mason

  - Cancer Nanotechnology - Year 2016

  Radiotherapy is currently used in around 50% of cancer treatments and relies on the deposition of energy directly into tumour tissue. Although it is generally effective, some of the deposited energy can adversely affect healthy tissue outside the tumour volume, especially in the case of photon radiation (gamma and X-rays). Improved radiotherapy outcomes can be achieved by employing ion beams due to the characteristic energy deposition...

  Full text available to download

• Targeting shelterin proteins for cancer therapy.

  Publication

  • W. Brankiewicz-Kopcinska
  • A. Kallingal
  • R. Krzemieniecki
  • M. Bagiński

  - DRUG DISCOVERY TODAY - Year 2024

  As a global health challenge, cancer prompts continuous exploration for innovative therapies that are also based on new targets. One promising avenue is targeting the shelterin protein complex, a safeguard for telomeres crucial in preventing DNA damage. The role of shelterin in modulating ataxia- telangiectasia mutated (ATM) and ataxia-telangiectasia and Rad3-related (ATR) kinases, key players in the DNA damage response (DDR),...

  Full text to download in external service